2017 - IPTA
This page contains exclusive content for the member of the following sections: TTS, CTS, IPITA, ISODP, IXA, ITA, TID, IHCTAS, IPTA. Log in to view.
Kidney I: Immunosuppression
201.1 - Efficacy and safety of everolimus with reduced tacrolimus and early steroid elimination regimen in de novo pediatric renal transplant recipients: 12-month data from the CRADLE study
Presenter: Burkhard, Toenshoff, Heidelberg, Germany
Authors: Burkhard Tönshoff, Robert Ettenger, Lars Pape, Luca Dello Strologo, El-Djouher Martzloff, Barbara Rauer, Jennifer Ng, Patricia Lopez, Anna Bjerre, Martin Christian, Stephen Marks
Important Disclaimer
By viewing the material on this site you understand and accept that:
- The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
- The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
- The material is solely for educational purposes for qualified health care professionals.
- The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
- The information cannot be used as a substitute for professional care.
- The information does not represent a standard of care.
- No physician-patient relationship is being established.
Contact
Address
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada